# Safety and Efficacy Study in Hepatitis C Patients With PHN121

> **NCT01052090** · PHASE1,PHASE2 · TERMINATED · sponsor: **PhytoHealth Corporation** · enrollment: 12 (actual)

## Conditions studied

- Hepatitis C Virus Infection

## Interventions

- **DRUG:** PHN121

## Key facts

- **NCT ID:** NCT01052090
- **Lead sponsor:** PhytoHealth Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052090, "Safety and Efficacy Study in Hepatitis C Patients With PHN121". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01052090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*